Insulin resistance and skeletal muscle vasculature: Significance, assessment and therapeutic modulators

CardioRenal Medicine

Volumn 4, Issue 3-4, 2014, Pages 244-256

  Manrique, Camila ^a,b,c   Sowers, James R ^a,b,c  

^a Division of Endocrinology   (United States)

^b University of Missouri   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Insulin resistance; Skeletal muscle vasculature; Type 2 diabetes mellitus

Indexed keywords

5' ADENOSINE MONOPHOSPHATE ACTIVATED KINASE; GLUCOSE; INSULIN; METFORMIN; PHOSPHOTRANSFERASE; UNCLASSIFIED DRUG; VASOACTIVE AGENT;

ARTICLE; BODY WEIGHT LOSS; CONTRAST-ENHANCED ULTRASOUND; DYE DILUTION CURVE; ENZYME ACTIVATION; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; GLUCOSE TRANSPORT; HUMAN; INSULIN RESISTANCE; INTRAVITAL MICROSCOPY; LIMB BLOOD FLOW; MICRODIALYSIS; MICROVASCULATURE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PHYSICAL ACTIVITY; PLETHYSMOGRAPHY; POSITRON EMISSION TOMOGRAPHY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SKELETAL MUSCLE; VASCULARIZATION;

EID: 84973466657     PISSN: 16643828     EISSN: 16645502     Source Type: Journal    
DOI: 10.1159/000368423     Document Type: Article

References (94)

1. Jeon JY, Ko SH, Kwon HS, Kim NH, Kim JH, Kim CS, Song KH, Won JC, Lim S, Choi SH, Jang M, Kim Y, Oh K, Kim DJ, Cha BY: Prevalence of diabetes and prediabetes according to fasting plasma glucose and HbA1c. Diabetes Metab J 2013;37:349–357.
2. DeFronzo RA, Ferrannini E: Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991;14:173–194.
3. Muniyappa R, Montagnani M, Koh KK, Quon MJ: Cardiovascular actions of insulin. Endocr Rev 2007;28:463–491.
4. Muniyappa R, Yavuz S: Metabolic actions of angiotensin II and insulin: a microvascular endothelial balancing act. Mol Cell Endocrinol 2013;378:59–69.
5. Manrique C, Lastra G, Sowers JR: New insights into insulin action and resistance in the vasculature. Ann NY Acad Sci 2014;1311:138–150.
6. Montagnani M, Ravichandran LV, Chen H, Esposito DL, Quon MJ: Insulin receptor substrate-1 and phos-phoinositide-dependent kinase-1 are required for insulin-stimulated production of nitric oxide in endothelial cells. Mol Endocrinol 2002;16:1931–1942.
7. Montagnani M, Golovchenko I, Kim I, Koh GY, Goalstone ML, Mundhekar AN, Johansen M, Kucik DF, Quon MJ, Draznin B: Inhibition of phosphatidylinositol 3-kinase enhances mitogenic actions of insulin in endothelial cells. J Biol Chem 2002;277:1794–1799.
8. Michel JB, Feron O, Sacks D, Michel T: Reciprocal regulation of endothelial nitric-oxide synthase by Ca2+-calmodulin and caveolin. J Biol Chem 1997;272:15583–15586.
9. Lin MI, Fulton D, Babbitt R, Fleming I, Busse R, Pritchard KA Jr, Sessa WC: Phosphorylation of threonine 497 in endothelial nitric-oxide synthase coordinates the coupling of L-arginine metabolism to efficient nitric oxide production. J Biol Chem 2003;278:44719–44726.
10. Pritchard KA Jr, Ackerman AW, Gross ER, Stepp DW, Shi Y, Fontana JT, Baker JE, Sessa WC: Heat shock protein 90 mediates the balance of nitric oxide and superoxide anion from endothelial nitric-oxide synthase. J Biol Chem 2001;276:17621–17624.
11. Crabtree M, Channon K: Synthesis and recycling of tetrahydrobiopterin in endothelial function and vascular disease. Nitric Oxide 2011;25:81–88.
12. Khimji A, Rockey D: Endothelin – biology and disease. Cell Signal 2010;22:1615–1625.
13. Ferri C, Pittoni V, Piccoli A, Laurenti O, Cassone MR, Bellini C, Properzi G, Valesini G, De Mattia G, Santucci A: Insulin stimulates endothelin-1 secretion from human endothelial cells and modulates its circulating levels in vivo. J Clin Endocrinol Metab 1995;80:829–835.
14. Bender SB, McGraw AP, Jaffe IZ, Sowers JR: Mineralocorticoid receptor-mediated vascular insulin resistance: an early contributor to diabetes-related vascular disease? Diabetes 2013;62:313–319.
15. DeFronzo R: Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009. Diabetologia 2010;53:1270–1287.
16. Rask-Madsen C, Kahn CR: Tissue-specific insulin signaling, metabolic syndrome, and cardiovascular disease. Arterioscler Thromb Vasc Biol 2012;32:2052–2059.
17. Sowers JR, Whaley-Connell A, Hayden MR: The role of overweight and obesity in the cardiorenal syndrome. Cardiorenal Med 2011;1:5–12.
18. Jia G, Aroor AR, Whaley-Connell AT, Sowers JR: Fructose and uric acid: is there a role in endothelial function? Curr Hypertens Rep 2014;16:434.
19. Thiebaud D, Jacot E, Defronzo RA, Maeder E, Jequier E, Felber J-P: The effect of graded doses of insulin on total glucose uptake, glucose oxidation, and glucose storage in man. Diabetes 1982;31:957–963.
20. Barrett EJ, Wang H, Upchurch CT, Liu Z: Insulin regulates its own delivery to skeletal muscle by feed-forward actions on the vasculature. Am J Physiol Endocrinol Metab 2011;301:E252–E263.
21. Saltin B, Radegran G, Koskolou M, Roach R: Skeletal muscle blood flow in humans and its regulation during exercise. Acta Physiol Scand 1998;162:421–436.
22. Klitzman B, Damon D, Gorczynski R, Duling B: Augmented tissue oxygen supply during striated muscle contraction in the hamster. Relative contributions of capillary recruitment, functional dilation, and reduced tissue PO2. Circ Res 1982;51:711–721.
23. Segal SS, Jacobs TL: Role for endothelial cell conduction in ascending vasodilatation and exercise hyperaemia in hamster skeletal muscle. J Physiol 2001;536:937–946.
24. Vincent MA, Barrett EJ, Lindner JR, Clark MG, Rattigan S: Inhibiting NOS blocks microvascular recruitment and blunts muscle glucose uptake in response to insulin. Am J Physiol Endocrinol Metab 2003;285:E123–E129.
25. Womack L, Peters D, Barrett E, Kaul S, Price W, Lindner J: Abnormal skeletal muscle capillary recruitment during exercise in patients with type 2 diabetes mellitus and microvascular complications. J Am Coll Cardiol 2009;53:2175–2183.
26. Clark MG: Impaired microvascular perfusion: a consequence of vascular dysfunction and a potential cause of insulin resistance in muscle. Am J Physiol Endocrinol Metab 2008:295:E732–E750.
27. Bradley EA, Clark MG, Rattigan S: Acute effects of wortmannin on insulin’s hemodynamic and metabolic actions in vivo. Am J Physiol Endocrinol Metab 2007;292:E779–E787.
28. MacLean DA, Ettinger SM, Sinoway LI, Lanoue KF: Determination of muscle-specific glucose flux using radioactive stereoisomers and microdialysis. Am J Physiol Endocrinol Metab 2001;280:E187–E192.
29. Barrett EJ, Rattigan S: Muscle perfusion: its measurement and role in metabolic regulation. Diabetes 2012;61: 2661–2668.
30. Joyner MJ, Dietz NM, Shepherd JT: From Belfast to Mayo and beyond: the use and future of plethysmography to study blood flow in human limbs. J Appl Physiol 2001;91:2431–2441.
31. Andres R, Zierler KL, Anderson HM, Stainsby WN, Cader G, Ghrayyib AS, Lilienthal JL Jr: Measurement of blood flow and volume in the forearm of man; with notes on the theory of indicator-dilution and on production of turbulence, hemolysis, and vasodilatation by intra-vascular injection. J Clin Invest 1954;33:482–504.
32. Carlier PG, Bertoldi D, Baligand C, Wary C, Fromes Y: Muscle blood flow and oxygenation measured by NMR imaging and spectroscopy. NMR Biomed 2006;19:954–967.
33. Bagher P, Segal SS: The mouse cremaster muscle preparation for intravital imaging of the microcirculation. J Vis Exp 2011:pii:2874.
34. Wölfle SE, Schmidt VJ, Hoepfl B, Gebert A, Alcoléa S, Gros D, de Wit C: Connexin45 cannot replace the function of connexin40 in conducting endothelium-dependent dilations along arterioles. Circ Res 2007;101:1292–1299.
35. Bagher P, Duan D, Segal SS: Evidence for impaired neurovascular transmission in a murine model of Duchenne muscular dystrophy. J Appl Physiol (1985) 2011:110:601–609.
36. Tallini YN, Brekke JF, Shui B, Doran R, Hwang SM, Nakai J, Salama G, Segal SS, Kotlikoff MI: Propagated endothelial Ca2+ waves and arteriolar dilation in vivo: measurements in Cx40BAC GCaMP2 transgenic mice. Circ Res 2007;101:1300–1309.
37. Novielli NM, Jackson DN: Contraction-evoked vasodilation and functional hyperaemia are compromised in branching skeletal muscle arterioles of young pre-diabetic mice. Acta Physiol (Oxf) 2014;211:371–384.
38. Liu Z, Ko SH, Chai W, Cao W: Regulation of muscle microcirculation in health and diabetes. Diabetes Metab J 2012;36:83–89.
39. Ruotsalainen U, Raitakari M, Nuutila P, Oikonen V, Sipila H, Teras M, Knuuti MJ, Bloomfield PM, Iida H: Quantitative blood flow measurement of skeletal muscle using oxygen-15- water and PET. J Nucl Med 1997;38: 314–319.
40. Thiebaud D, Jacot E, Defronzo RA, Maeder E, Jequier E, Felber J-P: The effect of graded doses of insulin on total glucose uptake, glucose oxidation, and glucose storage in man. Diabetes 1982;31:957–963.
41. Nuutila P1, Raitakari M, Laine H, Kirvelä O, Takala T, Utriainen T, Mäkimattila S, Pitkänen OP, Ruotsalainen U, Iida H, Knuuti J, Yki-Järvinen H: Role of blood flow in regulating insulin-stimulated glucose uptake in humans. Studies using bradykinin, [15O]water, and [18F]fluoro-deoxy-glucose and positron emission tomography. J Clin Invest 1996;97:1741–1747.
42. Clerk LH, Rattigan S, Clark MG: Lipid infusion impairs physiologic insulin-mediated capillary recruitment and muscle glucose uptake in vivo. Diabetes 2002;51:1138–1145.
43. Baron AD: Hemodynamic actions of insulin. Am J Physiol Endocrinol Metab 1994;267:E187–E202.
44. Baron AD, Laakso M, Brechtel G, Edelman SV: Mechanism of insulin resistance in insulin-dependent diabetes mellitus: a major role for reduced skeletal muscle blood flow. J Clin Endocrinol Metab 1991;73:637–643.
45. Baron AD, Laakso M, Brechtel G, Hoit B, Watt C, Edelman SV. Reduced postprandial skeletal muscle blood flow contributes to glucose intolerance in human obesity. J Clin Endocrinol Metab 1990;70:1525–1533.
46. Baron A, Steinberg H, Chaker H, Leaming R, Johnson A, Brechtel G: Insulin-mediated skeletal muscle vasodilation contributes to both insulin sensitivity and responsiveness in lean humans. J Clin Invest 1995;96:786–792.
47. Laakso M, Edelman S, Brechtel G, Baron A: Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance. J Clin Invest 1990;85:1844–1852.
48. Steinberg H, Brechtel G, Johnson A, Fineberg N, Baron A: Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J Clin Invest 1994;94:1172–1179.
49. Raitakari M, Nuutila P, Ruotsalainen U, Laine H, Teräs M, Iida H, Mäkimattila S, Utriainen T, Oikonen V, Sipilä H, Haaparanta M, Solin O, Wegelius U, Knuuti J, Yki-Järvinen H: Evidence for dissociation of insulin stimulation of blood flow and glucose uptake in human skeletal muscle: studies using [15O]H2O, [18F]fluoro-2-deoxy-D-glucose, and positron emission tomography. Diabetes 1996;45:1471–1477.
50. Ruotsalainen U1, Raitakari M, Nuutila P, Oikonen V, Sipilä H, Teräs M, Knuuti MJ, Bloomfield PM, Iida H: Quantitative blood flow measurement of skeletal muscle using oxygen-15-water and PET. J Nucl Med 1997;38: 314–319.
51. Coggins M, Lindner J, Rattigan S, Jahn L, Fasy E, Kaul S, Barrett E: Physiologic hyperinsulinemia enhances human skeletal muscle perfusion by capillary recruitment. Diabetes 2001;50:2682–2690.
52. Vincent MA, Dawson D, Clark ADH, Lindner JR, Rattigan S, Clark MG, Barrett EJ: Skeletal muscle microvascular recruitment by physiological hyperinsulinemia precedes increases in total blood flow. Diabetes 2002;51: 42–48.
53. Bradley EA, Richards SM, Keske MA, Rattigan S: Local NOS inhibition impairs vascular and metabolic actions of insulin in rat hindleg muscle in vivo. Am J Physiol Endocrinol Metab 2013;305:E745–E750.
54. Zhao L, Chai W, Fu Z, Dong Z, Aylor KW, Barrett EJ, Cao W, Liu Z: Globular adiponectin enhances muscle insulin action via microvascular recruitment and increased insulin delivery. Circ Res 2013;112:1263–1271.
55. Nikolaidis LA, Elahi D, Shen YT, Shannon RP: Active metabolite of GLP-1 mediates myocardial glucose uptake and improves left ventricular performance in conscious dogs with dilated cardiomyopathy. Am J Physiol Heart Circ Physiol 2005;289:15.
56. Drucker DJ: The biology of incretin hormones. Cell Metab 2006;3:153–165.
57. Chai W, Dong Z, Wang N, Wang W, Tao L, Cao W, Liu Z: Glucagon-like peptide 1 recruits microvasculature and increases glucose use in muscle via a nitric oxide-dependent mechanism. Diabetes 2012;61:888–896.
58. Lillioja S, Young AA, Culter CL, Ivy JL, Abbott WG, Zawadzki JK, Yki-Järvinen H, Christin L, Secomb TW, Bogardus C: Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man. J Clin Invest 1987;80:415–424.
59. Solomon TP, Haus JM, Li Y, Kirwan JP: Progressive hyperglycemia across the glucose tolerance continuum in older obese adults is related to skeletal muscle capillarization and nitric oxide bioavailability. J Clin Endocrinol Metab 2011;96:1377–1384.
60. Bonner JS, Lantier L, Hasenour CM, James FD, Bracy DP, Wasserman DH: Muscle-specific vascular endothelial growth factor deletion induces muscle capillary rarefaction creating muscle insulin resistance. Diabetes 2013; 62:572–580.
61. King GL, Johnson SM: Receptor-mediated transport of insulin across endothelial cells. Science 1985;227: 1583–1586.
62. Yang YJ, Hope ID, Ader M, Bergman RN: Insulin transport across capillaries is rate limiting for insulin action in dogs. J Clin Invest 1989;84:1620–1628.
63. Miles PD, Levisetti M, Reichart D, Khoursheed M, Moossa AR, Olefsky JM. Kinetics of insulin action in vivo. Identification of rate-limiting steps. Diabetes 1995;44:947–953.
64. Sjöstrand M, Gudbjörnsdottir S, Holmäng A, Lönn L, Strindberg L, Lönnroth P: Delayed transcapillary transport of insulin to muscle interstitial fluid in obese subjects. Diabetes 2002;51:2742–2748.
65. Cohen AW, Combs TP, Scherer PE, Lisanti MP: Role of caveolin and caveolae in insulin signaling and diabetes. Am J Physiol Endocrinol Metab 2003;285:E1151–E1160.
66. Wang H, Wang AX, Barrett EJ: Caveolin-1 is required for vascular endothelial insulin uptake. Am J Physiol Endocrinol Metab 2011;300:E134–E144.
67. Wang H, Wang AX, Liu Z, Barrett EJ: Insulin signaling stimulates insulin transport by bovine aortic endothelial cells. Diabetes 2008;57:540–547.
68. Wang H, Wang AX, Aylor K, Barrett EJ: Barrett nitric oxide directly promotes vascular endothelial insulin transport. Diabetes 2013;62:4030–4042.
69. Mehta PK, Griendling KK: Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 2007;292:C82–C97.
70. Retailleau K1, Belin de Chantemèle EJ, Chanoine S, Guihot AL, Vessières E, Toutain B, Faure S, Bagi Z, Loufrani L, Henrion D: Reactive oxygen species and cyclooxygenase 2-derived thromboxane A2 reduce angiotensin II type 2 receptor vasorelaxation in diabetic rat resistance arteries. Hypertension 2010;55:339–344.
71. Savoia C, Touyz RM, Volpe M, Schiffrin EL: Angiotensin type 2 receptor in resistance arteries of type 2 diabetic hypertensive patients. Hypertension 2007;49:341–346.
72. Funke-Kaiser H, Reinemund J, Steckelings UM, Unger T: Adapter proteins and promoter regulation of the angiotensin AT2 receptor – implications for cardiac pathophysiology. J Renin Angiotensin Aldosterone Syst 2010;11:7–17.
73. Chai W, Wang W, Liu J, Barrett EJ, Carey RM, Cao W, Liu Z: Angiotensin II type 1 and type 2 receptors regulate basal skeletal muscle microvascular volume and glucose use. Hypertension 2010;55:523–530.
74. Chai W, Wang W, Dong Z, Cao W, Liu Z: Angiotensin II receptors modulate muscle microvascular and metabolic responses to insulin in vivo. Diabetes 2011;60:2939–2946.
75. Muniyappa R, Sowers JR: Role of insulin resistance in endothelial dysfunction. Rev Endocr Metab Disord 2013; 14:5–12.
76. Keske MA, Clerk LH, Price WJ, Jahn LA, Barrett EJ: Obesity blunts microvascular recruitment in human forearm muscle after a mixed meal. Diabetes Care 2009;32:1672–1677.
77. Frisbee JC: Remodeling of the skeletal muscle microcirculation increases resistance to perfusion in obese Zucker rats. Am J Physiol Heart Circ Physiol 2003;285:H104–H111.
78. Jiang ZY, Lin YW, Clemont A, Feener EP, Hein KD, Igarashi M, Yamauchi T, White MF, King GL: Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats. J Clin Invest 1999; 104:447–457.
79. Potenza MA, Marasciulo FL, Chieppa DM, Brigiani GS, Formoso G, Quon MJ, Montagnani M: Insulin resistance in spontaneously hypertensive rats is associated with endothelial dysfunction characterized by imbalance between NO and ET-1 production. Am J Physiol Heart Circ Physiol 2005;289:H813–H822.
80. Albu JB, Heilbronn LK, Kelley DE, Smith SR, Azuma K, Berk ES, Pi-Sunyer FX, Ravussin E; Look AHEAD Adipose Research Group: Metabolic changes following a 1-year diet and exercise intervention in patients with type 2 diabetes. Diabetes 2010;59:627–633.
81. Xing W, Li Y, Zhang H, Mi C, Hou Z, Quon MJ, Gao F: Improvement of vascular insulin sensitivity by downregu-lation of GRK2 mediates exercise-induced alleviation of hypertension in spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 2013;305:H1111–H1119.
82. Taguchi K, Matsumoto T, Kamata K, Kobayashi T: G protein-coupled receptor kinase 2, with beta-arrestin 2, impairs insulin-induced Akt/endothelial nitric oxide synthase signaling in ob/ob mouse aorta. Diabetes 2012; 61:1978–1985.
83. Mikus CR, Roseguini BT, Uptergrove GM, Morris EM, Rector RS, Libla JL, Oberlin DJ, Borengasser SJ, Taylor AM, Ibdah JA, Laughlin MH, Thyfault JP: Voluntary wheel running selectively augments insulin-stimulated vasodilation in arterioles from white skeletal muscle of insulin-resistant rats. Microcirculation. 2012;19:729–738.
84. Pierce GL, Beske SD, Lawson BR, Southall KL, Benay FJ, Donato AJ, Seals DR: Weight loss alone improves conduit and resistance artery endothelial function in young and older overweight/obese adults. Hypertension 2008;52:72–79.
85. Bigornia SJ, Farb MG, Tiwari S, Karki S, Hamburg NM, Vita JA, Hess DT, Lavalley MP, Apovian CM, Gokce N: Insulin status and vascular responses to weight loss in obesity. J Am Coll Cardiol 2013;62:2297–2305.
86. Hamdy O, Ledbury S, Mullooly C, Jarema C, Porter S, Ovalle K, Moussa A, Caselli A, Caballero AE, Economides PA, Veves A, Horton ES: Lifestyle modification improves endothelial function in obese subjects with the insulin resistance syndrome. Diabetes Care 2003;26:2119–2125.
87. Maeda S, Jesmin S, Iemitsu M, Otsuki T, Matsuo T, Ohkawara K, Nakata Y, Tanaka K, Goto K, Miyauchi T: Weight loss reduces plasma endothelin-1 concentration in obese men. Exp Biol Med 2006;231:1044–1047.
88. Prior SJ, Blumenthal JB, Katzel LI, Goldberg AP, Ryan AS: Increased skeletal muscle capillarization after aerobic exercise training and weight loss improves insulin sensitivity in adults with IGT. Diabetes Care 2014;37:1469–1475.
89. Look AHEAD Research Group; Wing RR, Bolin P, et al: Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med 2013;369:145–154.
90. Katakam PV, Ujhelyi MR, Hoenig M, Miller AW: Metformin improves vascular function in insulin-resistant rats. Hypertension 2000;35:108–112.
91. Davis BJ, Xie Z, Viollet B, Zou MH: Activation of the AMP-activated kinase by antidiabetes drug metformin stimulates nitric oxide synthesis in vivo by promoting the association of heat shock protein 90 and endothelial nitric oxide synthase. Diabetes 2006;55:496–505.
92. Diamanti-Kandarakis E, Alexandraki K, Protogerou A, Piperi C, Papamichael C, Aessopos A, Lekakis J, Mavri-kakis M: Metformin administration improves endothelial function in women with polycystic ovary syndrome. Eur J Endocrinol 2005;152:749–756.
93. Hong J, Zhang Y, Lai S, Lv A, Su Q, Dong Y, Zhou Z, Tang W, Zhao J, Cui L, Zou D, Wang D, Li H, Liu C, Wu G, Shen J, Zhu D, Wang W, Shen W, Ning G; SPREAD-DIMCAD Investigators: Effects of metformin versus glipizide on cardiovascular outcomes in patients with type 2 diabetes and coronary artery disease. Diabetes Care 2013; 36:1304–1311.
94. Sola S, Mir MQ, Cheema FA, Khan-Merchant N, Menon RG, Parthasarathy S, Khan BV: Irbesartan and lipoic acid improve endothelial function and reduce markers of inflammation in the metabolic syndrome: results of the Irbesartan and Lipoic Acid in Endothelial Dysfunction (ISLAND) study. Circulation 2005;111:343–348.